Mpox Earlier Monkey Pox clinical trials

Explore recruiting mpox earlier monkey pox clinical trials.

Also recruiting in Europe

Mpox Earlier Monkey Pox trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immunogenicity and safety of a fractional subcutaneous booster booster vaccination against mpox with MVA-BN: a randomised-controlled non-inferiority study (SUBO-trial)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Mpox Earlier Monkey Pox trials by city

Mpox Earlier Monkey Pox in Toronto Mpox Earlier Monkey Pox in Vancouver Mpox Earlier Monkey Pox in Montreal Mpox Earlier Monkey Pox in Calgary Mpox Earlier Monkey Pox in Edmonton Mpox Earlier Monkey Pox in Ottawa Mpox Earlier Monkey Pox in Winnipeg Mpox Earlier Monkey Pox in Quebec City Mpox Earlier Monkey Pox in Hamilton Mpox Earlier Monkey Pox in Kitchener Mpox Earlier Monkey Pox in London Mpox Earlier Monkey Pox in Halifax Mpox Earlier Monkey Pox in New York Mpox Earlier Monkey Pox in Los Angeles Mpox Earlier Monkey Pox in Chicago Mpox Earlier Monkey Pox in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease